Publication:
Clinical Outcomes after Surgical Resection Combined with Brachytherapy for Uveal Melanomas.

dc.contributor.authorRelimpio-López, Isabel
dc.contributor.authorGarrido-Hermosilla, Antonio Manuel
dc.contributor.authorEspejo, Francisco
dc.contributor.authorGessa-Sorroche, María
dc.contributor.authorCoca, Lourdes
dc.contributor.authorDomínguez, Belen
dc.contributor.authorDíaz-Granda, María Jesús
dc.contributor.authorPonte, Beatriz
dc.contributor.authorCano, María José
dc.contributor.authorRodríguez de la Rúa, Enrique
dc.contributor.authorCarrasco-Peña, Francisco
dc.contributor.authorMíguez, Carlos
dc.contributor.authorSaavedra, Jonathan
dc.contributor.authorOntanilla, Antonio
dc.contributor.authorCaparrós-Escudero, Carlos
dc.contributor.authorRíos, Juan José
dc.contributor.authorTerrón, José Antonio
dc.date.accessioned2023-05-03T14:05:43Z
dc.date.available2023-05-03T14:05:43Z
dc.date.issued2022-03-15
dc.description.abstractCurrently, brachytherapy is the most commonly used therapeutic approach for uveal melanomas. Surgical resection by means of endoresection or exoresection is an alternative approach. The present report recounts our experience over 15 years in the treatment of uveal melanoma using a combined approach of resection surgery with brachytherapy. This is a single-center observational retrospective cohort study in which we describe clinical outcomes, complications and survival in 35 cases of melanoma of the iris or the ciliary body after a combination of surgery and brachytherapy or brachytherapy alone. Local treatment of the tumor was successful in all cases with surgery and brachytherapy. The most frequent complications were scleromalacia, bullous keratopathy, retinal toxicity, cataracts, hypotonia, and photophobia. There were three cases of recurrence, all of which were found in the group of patients who had received brachytherapy alone, and in one case we had to perform a secondary enucleation due to tumor growth after brachytherapy. At present, only one patient has died during follow-up due to liver metastases six years after the start of treatment. In carefully selected patients, this approach can be effective and safe, as long as a close follow-up is carried out after surgery.
dc.identifier.doi10.3390/jcm11061616
dc.identifier.issn2077-0383
dc.identifier.pmcPMC8956023
dc.identifier.pmid35329942
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956023/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2077-0383/11/6/1616/pdf?version=1647328608
dc.identifier.urihttp://hdl.handle.net/10668/21256
dc.issue.number6
dc.journal.titleJournal of clinical medicine
dc.journal.titleabbreviationJ Clin Med
dc.language.isoen
dc.organizationHospital Universitario Virgen Macarena
dc.organizationHospital Universitario Virgen Macarena
dc.organizationHospital Universitario Virgen Macarena
dc.organizationHospital Universitario Virgen Macarena
dc.organizationHospital Universitario Virgen Macarena
dc.organizationHospital Universitario Virgen Macarena
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectbrachytherapy
dc.subjectexoresection
dc.subjectsurgery
dc.subjectuveal melanoma
dc.titleClinical Outcomes after Surgical Resection Combined with Brachytherapy for Uveal Melanomas.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number11
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC8956023.pdf
Size:
9.69 MB
Format:
Adobe Portable Document Format